Currently available methods for allelic types discrimination of HER2 gene polymorphisms of breast cancer patients are (1) PCR-RLFP and (2) Real-Time PCR using Taq Man-based or dual colour-based [17]. Here, ERBB2 is linked to breast carcinoma.